Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129195) titled 'Phase Ib/II Clinical Study of Neoadjuvant Carbon Ion Radiotherapy Combined with Immunotherapy for Head and Neck Squamous Cell Carcinoma' on July 31.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Zhejiang Cancer Hospital

Condition: local advanced squamous cacinoma of head and neck

Recruitment Status: Not Recruiting

Phase: 1-2

Date of First Enrollment: 2026-08-01

Target Sample Size: experiment:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=333295

Published by HT Digital Content Services with permission from Health Dail...